Sitagliptin-metformin therapy in newly diagnosed type 2 diabetes

Sitagliptin-metformin therapy in newly diagnosed type 2 diabetes - Sitagliptin-metformin therapy in newly diagnosed type 2 diabetes

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054803

Enrollment

128

Registered

2024-06-28

Start date

2024-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes mellitus

Interventions

sitagliptin-metformin metformin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 2 Diabetes mellitus

Exclusion criteria

Exclusion criteria: Severe disease

Design outcomes

Primary

Measure	Time frame
Glycemic control	—

Countries

Africa

Contacts

Public ContactHosam Ahmad

Egypt Ministry of Health and population Biomedical Chemistry

hosam.refaei1@gmail.com01000638308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026